Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Weiwei Yan, Tingting Xu, Hui Zhu & Jinming Yu. (2020) Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors. OncoTargets and Therapy 13, pages 719-731.
Read now
Read now
Claire Roddie & Karl S Peggs. (2014) Emerging options for the treatment of melanoma – focus on ipilimumab. ImmunoTargets and Therapy 3, pages 67-78.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:1.
Read now
Read now
Gianfranco Baronzio, Gurdev Parmar, Irina ZH Shubina, Valter Cassutti, Sergio Giuli, Marco Ballerini & Mikhail Kiselevsky. (2013) Update on the challenges and recent advances in cancer immunotherapy. ImmunoTargets and Therapy 2, pages 39-49.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jerome Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:8.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:5.
Read now
Read now
Articles from other publishers (31)
Merve Hasanov, Denái R Milton, Alicia Bea Davies, Elizabeth Sirmans, Chantal Saberian, Eliza L Posada, Sylvia Opusunju, Jeffrey E Gershenwald, Carlos A Torres-Cabala, Elizabeth M Burton, Rivka R Colen, Jason T Huse, Isabella C Glitza Oliva, Caroline Chung, Mary Frances McAleer, Susan L McGovern, Debra N Yeboa, Betty Y S Kim, Sujit S Prabhu, Ian E McCutcheon, Jeffrey S Weinberg, Frederick F Lang, Hussein A Tawbi, Jing Li, Lauren E Haydu, Michael A Davies & Sherise D Ferguson. (2023) Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro-Oncology 25:7, pages 1310-1320.
Crossref
Crossref
Qiuchi Chen, Jie Xiong, Yuxi Ma, Jielin Wei, Cuiwei Liu & Yanxia Zhao. (2023) Systemic treatments for breast cancer brain metastasis. Frontiers in Oncology 12.
Crossref
Crossref
Tanja Eisemann & Robert J. Wechsler-Reya. (2022) Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma. Genes & Development 36:9-10, pages 514-532.
Crossref
Crossref
Jawad Fares, Ilya Ulasov, Peter Timashev & Maciej S Lesniak. (2021) Emerging principles of brain immunology and immune checkpoint blockade in brain metastases. Brain 144:4, pages 1046-1066.
Crossref
Crossref
Angela M. Hong, Cora Waldstein, Brindha Shivalingam, Matteo S. Carlino, Victoria Atkinson, Richard F. Kefford, Grant A. McArthur, Alexander M. Menzies, John F. Thompson & Georgina V. Long. (2021) Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia. European Journal of Cancer 142, pages 10-17.
Crossref
Crossref
Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, Takashi Inozume, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Takamichi Ito, Keisuke Imafuku, Ryota Tanaka, Yukiko Teramoto, Akane Minagawa, Takuya Miyagawa, Azusa Miyashita, Makoto Wada, Hiroshi Koga & Makoto Sugaya. (2019) Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. The Journal of Dermatology 47:2, pages 89-103.
Crossref
Crossref
Orit Kaidar-Person, Michael Cools & Timothy Zagar. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
794
808.e3
.
Ekrem Emrah Er & Adrienne Boire. 2020. Central Nervous System Metastases. Central Nervous System Metastases
31
41
.
Ali S. Haider, Raymond Sawaya & Sherise D. Ferguson. 2020. Central Nervous System Metastases. Central Nervous System Metastases
191
198
.
Andreas Teufel, Tianzuo Zhan, Nicolai Härtel, Jan Bornschein, Matthias P. Ebert & Nadine Schulte. (2019) Management of immune related adverse events induced by immune checkpoint inhibition. Cancer Letters 456, pages 80-87.
Crossref
Crossref
Michael Schulz, Anna Salamero-Boix, Katja Niesel, Tijna Alekseeva & Lisa Sevenich. (2019) Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis. Frontiers in Immunology 10.
Crossref
Crossref
Jacob S. Young, Fara Dayani, Ramin A. Morshed, Hideho Okada & Manish K. Aghi. (2019) Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. World Neurosurgery 124, pages 397-409.
Crossref
Crossref
Lisa Sevenich. (2019) Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers. Frontiers in Oncology 9.
Crossref
Crossref
Niyanta N. Kumar, Michelle E. Pizzo, Geetika Nehra, Brynna Wilken-Resman, Sam Boroumand & Robert G. Thorne. (2018) Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches. Bioconjugate Chemistry 29:12, pages 3937-3966.
Crossref
Crossref
Vishal Jindal & Sorab Gupta. (2018) Expected Paradigm Shift in Brain Metastases Therapy—Immune Checkpoint Inhibitors. Molecular Neurobiology 55:8, pages 7072-7078.
Crossref
Crossref
Gabriele Romano & Lawrence N. Kwong. (2017) Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy. Cancer and Metastasis Reviews 37:1, pages 45-53.
Crossref
Crossref
Vyshak Alva Venur, Vidhya Karivedu & Manmeet S. Ahluwalia. 2018. Metastatic Disease of the Nervous System. Metastatic Disease of the Nervous System
137
153
.
Chen Fu, Dan S. Gombos, Jared Lee, Goldy C. George, Kenneth Hess, Andrew Whyte & David S. Hong. (2017) Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions. Oncotarget 8:35, pages 58709-58727.
Crossref
Crossref
Orit Kaidar-Person, Timothy M. Zagar, Allison Deal, Stergios J. Moschos, Matthew G. Ewend, Deanna Sasaki-Adams, Carrie B. Lee, Frances A. Collichio, David Fried, Lawrence B. Marks & Bhishamjit S. Chera. (2017) The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases. Anti-Cancer Drugs 28:6, pages 669-675.
Crossref
Crossref
Paul Letendre, Varun Monga, Mohammed Milhem & Yousef Zakharia. (2017) Ipilimumab: from preclinical development to future clinical perspectives in melanoma. Future Oncology 13:7, pages 625-636.
Crossref
Crossref
Andrea Forschner, Felizitas Eichner, Teresa Amaral, Ulrike Keim, Claus Garbe & Thomas Kurt Eigentler. (2016) Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR). Journal of Cancer Research and Clinical Oncology 143:3, pages 533-540.
Crossref
Crossref
Ahmed K. Alomari, Justine Cohen, Alexander O. Vortmeyer, Anne Chiang, Scott Gettinger, Sarah Goldberg, Harriet M. Kluger & Veronica L. Chiang. (2016) Possible Interaction of Anti–PD-1 Therapy with the Effects of Radiosurgery on Brain Metastases. Cancer Immunology Research 4:6, pages 481-487.
Crossref
Crossref
Anna S. BerghoffVyshak A. VenurMatthias PreusserManmeet S. Ahluwalia. (2016) Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment. American Society of Clinical Oncology Educational Book:36, pages e116-e122.
Crossref
Crossref
Justine V. Cohen, Ahmed K. Alomari, Alexander O. Vortmeyer, Lucia B. Jilaveanu, Sarah B. Goldberg, Amit Mahajan, Veronica L. Chiang & Harriet M. Kluger. (2016) Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment. Cancer Immunology Research 4:3, pages 179-182.
Crossref
Crossref
Gerald B. Fogarty & Angela Hong. (2014) Radiation therapy for advanced and metastatic melanoma. Journal of Surgical Oncology 109:4, pages 370-375.
Crossref
Crossref
Julia Tichy & Joachim P. Steinbach. (2014) Hirnmetastasen — Alles zu spät?. NeuroTransmitter 25:1, pages 38-44.
Crossref
Crossref
Lucio Tentori, Pedro Miguel Lacal & Grazia Graziani. (2013) Challenging resistance mechanisms to therapies for metastatic melanoma. Trends in Pharmacological Sciences 34:12, pages 656-666.
Crossref
Crossref
Jack Murrell & Ruth Board. (2013) The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: Opportunities and unanswered questions. Cancer Treatment Reviews 39:8, pages 833-838.
Crossref
Crossref
Aki Morikawa, Komal Jhaveri & Andrew D. Seidman. (2013) Clinical Trials for Breast Cancer with Brain Metastases: Challenges and New Directions. Current Breast Cancer Reports 5:4, pages 293-301.
Crossref
Crossref
Lisa Pappas-Taffer, Misha Rosenbach & Emily Y. Chu. (2013) The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma. Current Dermatology Reports 2:2, pages 84-100.
Crossref
Crossref
Georg Feldmann, Peter Brossart, Matthias Zipfel & Marie von Lilienfeld-Toal. (2013) Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature. Case Reports in Oncology 6:1, pages 229-235.
Crossref
Crossref